Article

You have full text access to this OnlineOpen article

Elucidating the role of Trp105 in the KPC-2 β-lactamase

  1. Krisztina M. Papp-Wallace1,4,
  2. Magdalena Taracila1,4,
  3. Christopher J. Wallace1,4,
  4. Kristine M. Hujer1,4,
  5. Christopher R. Bethel4,
  6. John M. Hornick4,
  7. Robert A. Bonomo1,2,3,4,*

Article first published online: 26 JUL 2010

DOI: 10.1002/pro.454

Issue

Protein Science

Protein Science

Volume 19, Issue 9, pages 1714–1727, September 2010

Additional Information

How to Cite

Papp-Wallace, K. M., Taracila, M., Wallace, C. J., Hujer, K. M., Bethel, C. R., Hornick, J. M. and Bonomo, R. A. (2010), Elucidating the role of Trp105 in the KPC-2 β-lactamase. Protein Science, 19: 1714–1727. doi: 10.1002/pro.454

Author Information

  1. 1

    Department of Medicine, Case Western Reserve University, Cleveland, Ohio 44106

  2. 2

    Department of Pharmacology, Case Western Reserve University, Cleveland, Ohio 44106

  3. 3

    Department of Molecular Biology and Microbiology, Case Western Reserve University, Cleveland, Ohio 44106

  4. 4

    Research Service, Louis Stokes Cleveland Veteran Affairs Medical Center, Cleveland, Ohio 44106

*Infectious Diseases Section, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, 10701 East Blvd., Cleveland, Ohio 44106

Publication History

  1. Issue published online: 23 AUG 2010
  2. Article first published online: 26 JUL 2010
  3. Manuscript Revised: 23 JUN 2010
  4. Manuscript Accepted: 23 JUN 2010
  5. Manuscript Received: 24 MAY 2010

Funded by

  • The Veterans Affairs Merit Review Program
  • National Institutes of Health. Grant Number: RO1 AI063517-01
  • Veterans Integrated Service Network 10 Geriatric Research, Education, and Clinical Center. Grant Number: VISN 10 GRECC

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (802K)

References

  • 1
    Kattan JN, Villegas MV, Quinn JP ( 2008) New developments in carbapenems. Clin Microbiol Infect 14: 1102–1111.
    Direct Link:
  • 2
    Ke W, Bethel CR, Thomson JM, Bonomo RA, van den Akker F ( 2007) Crystal structure of KPC-2: insights into carbapenemase activity in class A beta-lactamases. Biochemistry 46: 5732–5740.
  • 3
    Girlich D, Poirel L, Nordmann P ( 2009) Novel ambler class A carbapenem-hydrolyzing {beta}-lactamase, from a Pseudomonas fluorescens in the Seine River, Paris, France. Antimicrob Agents Chemother 54: 328–332.
  • 4
    Henriques I, Moura A, Alves A, Saavedra MJ, Correia A ( 2004) Molecular characterization of a carbapenem-hydrolyzing class A beta-lactamase, SFC-1, from Serratia fonticola UTAD54. Antimicrob Agents Chemother 48: 2321–2324.
  • 5
    Queenan AM, Bush K ( 2007) Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev 20: 440–458.
  • 6
    Poirel L, Weldhagen GF, Naas T, De Champs C, Dove MG, Nordmann P ( 2001) GES-2, a class A beta-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem. Antimicrob Agents Chemother 45: 2598–2603.
  • 7
    Endimiani A, Hujer AM, Perez F, Bethel CR, Hujer KM, Kroeger J, Oethinger M, Paterson DL, Adams MD, Jacobs MR, Diekema DJ, Hall GS, Jenkins SG, Rice LB, Tenover FC, Bonomo RA ( 2009) Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA. J Antimicrob Chemother 63: 427–437.
  • 8
    Oelschlaeger P, Ai N, Duprez KT, Welsh WJ, Toney JH ( 2010) Evolving carbapenemases: can medicinal chemists advance one step ahead of the coming storm? J Med Chem 53: 3013–3027.
  • 9
    Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, Alberti S, Bush K, Tenover FC ( 2001) Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 45: 1151–1161.
  • 10
    Yigit H, Queenan AM, Rasheed JK, Biddle JW, Domenech-Sanchez A, Alberti S, Bush K, Tenover FC ( 2003) Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenem-hydrolyzing beta-lactamase KPC-2. Antimicrob Agents Chemother 47: 3881–3889.
  • 11
    Papp-Wallace KM, Bethel CR, Distler AM, Kasuboski C, Taracila M, Bonomo RA ( 2010) Inhibitor resistance in the KPC-2 beta-lactamase, a preeminent property of this class A beta-lactamase. Antimicrob Agents Chemother 54: 890–897.
  • 12
    Petrella S, Ziental-Gelus N, Mayer C, Renard M, Jarlier V, Sougakoff W ( 2008) Genetic and structural insights into the dissemination potential of the extremely broad-spectrum class A beta-lactamase KPC-2 identified in an Escherichia coli strain and an Enterobacter cloacae strain isolated from the same patient in France. Antimicrob Agents Chemother 52: 3725–3736.
  • 13
    Ambler RP ( 1980) The structure of beta-lactamases. Philos Trans R Soc Lond B Biol Sci 289: 321–331.
  • 14
    Papp-Wallace KM, Taracila MS, Endimiani A, Hujer AM, Hujer KM, Distler AM, Hornick JM, Bonomo RA ( 2010) Substrate selectivity and a novel role in inhibitor discrimination by position 237 in the KPC-2 β-lactamase. Antimicrob Agents Chemother 54: 2867–2877.
  • 15
    Doucet N, De Wals PY, Pelletier JN ( 2004) Site-saturation mutagenesis of Tyr-105 reveals its importance in substrate stabilization and discrimination in TEM-1 beta-lactamase. J Biol Chem 279: 46295–46303.
  • 16
    Doucet N, Pelletier JN ( 2007) Simulated annealing exploration of an active-site tyrosine in TEM-1 beta-lactamase suggests the existence of alternate conformations. Proteins 69: 340–348.
    Direct Link:
  • 17
    Doucet N, Savard PY, Pelletier JN, Gagne SM ( 2007) NMR investigation of Tyr105 mutants in TEM-1 beta-lactamase: dynamics are correlated with function. J Biol Chem 282: 21448–21459.
  • 18
    Queenan AM, Shang W, Flamm R, Bush K ( 2009) Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem and meropenem. Antimicrob Agents Chemother 54: 565–569.
  • 19
    Page MG ( 2000) b-Lactamase inhibitors. Drug Resist Updat 3: 109–125.
  • 20
    Mourey L, Miyashita K, Swaren P, Bulychev A, Samama JP, Mobashery S ( 1998) Inhibition of the NMC-A β-lactamase by a penicillanic acid derivative and the structural bases for the increase in substrate profile of this antibiotic resistance enzyme. J Am Chem Soc 120: 9382–9383.
  • 21
    Taibi P, Mobashery S ( 1995) Mechanism of turnover of imipenem by the TEM .beta.-lactamase revisited. J Am Chem Soc 117: 7600–7605.
  • 22
    Frase H, Shi Q, Testero SA, Mobashery S, Vakulenko SB ( 2009) Mechanistic basis for the emergence of catalytic competence against carbapenem antibiotics by the GES family of beta-lactamases. J Biol Chem 284: 29509–29513.
  • 23
    CLSI ( 2007) CLSI Performance Standards for Antimicrobial Susceptibility Testing. Eighteen Informational Supplement. Wayne, PA: Clinical and Laboratory Standards Institute. CLSI M100-S17.
View Full Article (HTML) Get PDF (802K)